| 0.7 0.011 (1.6%) | 10-04 11:31 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.02 | 1-year : | 1.17 |
| Resists | First : | 0.87 | Second : | 1 |
| Pivot price | 0.72  |
|||
| Supports | First : | 0.66 | Second : | 0.54 |
| MAs | MA(5) : | 0.68 |
MA(20) : | 0.76 |
| MA(100) : | 0.97 |
MA(250) : | 1.1 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 8.2 |
D(3) : | 9.1 |
| RSI | RSI(14): 28.1 |
|||
| 52-week | High : | 1.59 | Low : | 0.66 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ZTEK ] has closed above bottom band by 17.5%. Bollinger Bands are 7.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.7 - 0.71 | 0.71 - 0.72 |
| Low: | 0.66 - 0.66 | 0.66 - 0.67 |
| Close: | 0.66 - 0.67 | 0.67 - 0.68 |
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Thu, 26 Sep 2024
Zentek Announces Voting Results of Annual and Special Meeting - StockTitan
Fri, 13 Sep 2024
Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - Newsfile
Fri, 13 Sep 2024
Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - StockTitan
Wed, 14 Aug 2024
Zentek Announces Upsize to Non-Brokered Private Placement of Units - Yahoo Finance
Wed, 14 Aug 2024
Zentek Announces Normal Course Issuer Bid - StockTitan
Thu, 27 Jul 2023
Zentek Ltd (ZEN-X) Quote - Press Release - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 104 (M) |
| Held by Insiders | 9.616e+007 (%) |
| Held by Institutions | 6 (%) |
| Shares Short | 557 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.075e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -44 % |
| Return on Assets (ttm) | 930.9 % |
| Return on Equity (ttm) | -27.1 % |
| Qtrly Rev. Growth | 35300 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -56.87 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -0.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.02 |
| Price to Cash Flow | 3.17 |
| Dividend | 0 |
| Forward Dividend | 556270 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|